Fetal Gender and Gestational-age-related Incidence of Pre-eclampsia
Overview
Affiliations
Background: Male fetal gender is associated with an overall increased risk of pre-eclampsia. However, it was recently shown that the male: female birth ratio was decreased in pre-eclampsia associated with preterm delivery. The reason for this discrepancy is not known.
Objective: To investigate whether the fetal and newborn gender is associated with the incidence of antenatal maternal pregnancy complications, and to investigate if gender-associated risk changes with gestational age at delivery.
Methods: Population-based study including 1,158,276 infants born in Sweden 1990-2001. Five maternal diagnosis groups (pre-eclampsia, infection, preterm premature rupture of membranes, abruptio placentae, and polyhydramnios) were explored in relation to newborn infant gender and gestational age at delivery.
Results: When all gestational ages were evaluated, male newborn gender was associated with increased odds ratios for all five diagnosis groups, and for preterm birth before 37 weeks gestation, M/F ratio 1.17. In very preterm births (gestational age below 32 weeks), male newborn gender was associated with a significantly lower risk for pre-eclampsia (OR 0.88, 95%CI 0.80-0.97), and a marginally lower risk for polyhydramnios (OR 0.74, 95%CI 0.54-1.01).
Conclusion: The fetal gender seems to affect the occurrence of pre-eclampsia, and possibly also polyhydramnios. The finding could be due to an increased risk for spontaneous abortions in pregnancies with male fetuses, but could also be associated with the etiology of these conditions. Evaluation of antenatal pregnancy complications from a fetal/newborn gender perspective may contribute to new insights regarding their pathophysiological mechanisms.
Sex-specific phenotypical, functional and metabolic profiles of human term placenta macrophages.
Paparini D, Grasso E, Aguilera F, Arslanian M, Lella V, Lara B Biol Sex Differ. 2024; 15(1):80.
PMID: 39420346 PMC: 11484421. DOI: 10.1186/s13293-024-00652-w.
Elevated gestational testosterone impacts vascular and uteroplacental function.
Kumar S, Song R, Mishra J Placenta. 2023; 157:14-20.
PMID: 37977936 PMC: 11087376. DOI: 10.1016/j.placenta.2023.11.004.
Freedman A, Roell K, Engwall E, Bulka C, Kuban K, Herring L Int J Mol Sci. 2023; 24(19).
PMID: 37834424 PMC: 10573797. DOI: 10.3390/ijms241914977.
Funaki S, Ogawa K, Ozawa N, Hosoya S, Okamoto A, Urayama K Arch Gynecol Obstet. 2022; 307(5):1397-1405.
PMID: 35624168 DOI: 10.1007/s00404-022-06623-z.
Parity status and the relationship between antenatal rubella serology with obstetric outcome.
Lao T, Hui S, Sahota D Sci Rep. 2022; 12(1):1278.
PMID: 35075197 PMC: 8786935. DOI: 10.1038/s41598-022-05376-8.